Latest share price

Current

645.00p

Average

-5.00p LSE

-0.77% 15 min delay

View chart

Results, reports & presentations

Our financial reports, corporate presentations, webcasts and audio can be found in this section.

Go

Latest press releases

26/06/2019

Oxford Biomedica and Santen enter R&D collaboration and Option &...

Read more

06/06/2019

Oxford Biomedica notes Axovant's six-month update from first cohort of...

Read more

30/05/2019

Exercise of Subscription Option by Novo Holdings

Read more

See all

Regulatory news

Message from the CEO
John Dawson

 

Message from the CEO 
John Dawson

Management and DirectorsGo

Shareholder meetings, circulars, and prospectusesGo

Analyst coverageGo

Corporate governanceGo

Financial calendarGo

Investor contactsGo

Email alertsGo